PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Tandem Diabetes Care, Inc investors: Please contact the Portnoy Law Firm to recover your losses; November 2, 2023 deadline
07 nov. 2023 15h47 HE | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Tandem Diabetes Care, Inc....
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Tandem Diabetes Care, Inc investors: Please contact the Portnoy Law Firm to recover your losses; November 2, 2023 deadline.
01 nov. 2023 20h03 HE | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Tandem Diabetes Care, Inc....
Robbins LLP logo white Background.png
Tandem Diabetes Care, Inc. Investors: Lead Plaintiff Deadline is Approaching in the Class Action Against Tandem Diabetes Care, Inc.; Contact Robbins LLP Today
05 oct. 2023 14h59 HE | Robbins LLP
Tandem Diabetes Care, Inc. (TNDM) Misled Investors Regarding Revenue Projections
Robbins LLP logo white Background.png
TNDM Shareholders Who Have Lost Money in the Stock Should Contact Robbins LLP for Information About the Class Action Against Tandem Diabetes Care, Inc.
28 sept. 2023 11h05 HE | Robbins LLP
Tandem Diabetes Care, Inc. (TNDM) Misled Investors Regarding Revenue Projections
Robbins LLP logo white Background.png
TNDM Shareholder Alert: Investors with Large Losses Should Contact Robbins LLP for Information About Recovery Against Tandem Diabetes Care, Inc.
21 sept. 2023 18h52 HE | Robbins LLP
SAN DIEGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes...
Robbins LLP logo white Background.png
Tandem Diabetes Care, Inc. (TNDM) Investor Alert: Robbins LLP Reminds Investors of Class Action Filed Against Tandem Diabetes Care, Inc.
15 sept. 2023 13h52 HE | Robbins LLP
SAN DIEGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes...